We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

157 hedge funds and large institutions have $817M invested in Intersect ENT, Inc in 2017 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 52 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

733% more call options, than puts

Call options by funds: $5.8M | Put options by funds: $696K

142% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 12

12% more funds holding

Funds holding: 140157 (+17)

4% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 52

3% more capital invested

Capital invested by funds: $792M → $817M (+$25.3M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
157
Holders Change
+17
Holders Change %
+12.14%
% of All Funds
3.56%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
54
Reduced
52
Closed
12
Calls
$5.8M
Puts
$696K
Net Calls
+$5.1M
Net Calls Change
+$322K
Name Holding Trade Value Shares
Change
Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$102M +$1.07M +35,723 +1%
Jennison Associates
2
Jennison Associates
New York
$66M +$11.2M +372,320 +22%
BlackRock
3
BlackRock
New York
$64.2M +$1.19M +39,761 +2%
DM
4
Deerfield Management
New York
$47.6M +$7.75M +258,341 +21%
AllianceBernstein
5
AllianceBernstein
Tennessee
$47.5M +$4.85M +161,723 +12%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$42.3M -$33.6M -1,119,590 -46%
Vanguard Group
7
Vanguard Group
Pennsylvania
$41M +$1.47M +49,083 +4%
Federated Hermes
8
Federated Hermes
Pennsylvania
$39.2M +$19.3K +645 +0.1%
Neuberger Berman Group
9
Neuberger Berman Group
New York
$23.6M -$2.24M -74,561 -9%
Adage Capital Partners
10
Adage Capital Partners
Massachusetts
$21.7M +$5.09M +169,632 +34%
State Street
11
State Street
Massachusetts
$18.5M -$448K -14,939 -3%
Point72 Asset Management
12
Point72 Asset Management
Connecticut
$16.5M +$15.3M +509,550 New
Lord, Abbett & Co
13
Lord, Abbett & Co
New Jersey
$11.7M -$256K -8,523 -2%
Northern Trust
14
Northern Trust
Illinois
$11.4M -$107K -3,580 -1%
RSCM
15
Rock Springs Capital Management
Maryland
$11.2M
Renaissance Technologies
16
Renaissance Technologies
New York
$10.3M +$2.06M +68,803 +28%
Millennium Management
17
Millennium Management
New York
$9.65M -$2.68M -89,456 -23%
TA
18
Teachers Advisors
New York
$9.36M +$6.66M +222,195 +334%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$8.31M +$351K +11,701 +5%
Thrivent Financial for Lutherans
20
Thrivent Financial for Lutherans
Minnesota
$8.3M +$623K +20,770 +9%
NI
21
Numeric Investors
Massachusetts
$7.82M +$2.01M +67,104 +39%
Citigroup
22
Citigroup
New York
$7.49M +$1.79M +59,528 +35%
Bank of America
23
Bank of America
North Carolina
$6.95M -$1.19M -39,562 -16%
KIA
24
Kopp Investment Advisors
Minnesota
$6.54M -$673K -22,429 -10%
MCM
25
Matarin Capital Management
New York
$5.94M +$4.84M +161,296 +731%

XENT Hedge Fund Activity: Q4 2017 in Review

157 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q4 2017, worth a combined $817M — up 3.2% from $792M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new XENT positions and 12 closed out — a net gain of 17 holders — while 54 added to existing stakes and 52 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $15.3M. The largest seller was Fidelity Investments, cutting an estimated $33.6M.

  • 157 institutional investors held Intersect ENT, Inc (XENT) as of Q4 2017, up from 140 in Q3 2017.
  • Funds reported $817M of Intersect ENT, Inc stock for Q4 2017, up 3.2% quarter-over-quarter.
  • 29 funds opened new Intersect ENT, Inc positions in Q4 2017 and 12 closed out, a net change of +17 holders.
  • The largest Intersect ENT, Inc buyer in Q4 2017 was Point72 Asset Management, an estimated $15.3M added.
  • The largest Intersect ENT, Inc seller in Q4 2017 was Fidelity Investments, an estimated $33.6M sold.

Based on aggregated 13F filings for Q4 2017.